Refine by
Laboratory Data Management Articles & Analysis
13 news found
Cytokine, a subdivision of Creative Proteomics, specializes in providing cytokine research and analytical services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Recently, the product manager of the company was pleased to announce the launch of its Cancer Cytokines Assay, assisting in the detection of ...
Cytokine, a subdivision of Creative Proteomics, specializes in providing cytokine research and analytical services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Recently, the product manager of the company is pleased to announce the launch of the growth factors (GF) detection service for further ...
“Due to its high sensitivity, resolution, and mass accuracy, our high-resolution mass spectrometry can well confirm the primary structure of fusion proteins and comprehensively characterize fusion protein glycosylation at the level of intact proteins, glycopeptides, and free sugars,” stated Creative Proteomics Pronalyse’s project manager. By combining advanced ...
We will choose the most proper technology combination according to your project, meet your various needs, and help researchers obtain higher-quality scientific research data,” stated Creative Proteomics’s senior scientist. “To identify specific cytokines involved in any inflammatory or immune response, we often need to screen for cytokines, which requires ...
We will choose the right technology combination according to your project, meet your various needs, and help researchers obtain higher-quality scientific research data,” stated Creative Proteomics’s senior scientist. Creative Proteomics can provide a tumor necrosis factor detection platform for scientific research. ...
Creative Proteomics Cytokine recently announced Disease Cytokine Assays to help researchers obtain higher quality scientific research data. Cytokines, including interleukins, interferons, tumor necrosis factors, and chemokines, can play key pro- and anti-inflammatory roles in vivo through a variety of biochemical pathways and interactions. ...
The different microspheres can be combined freely to a certain extent, so that up to 100 analytes can be tested multiple times simultaneously in a single experiment,” stated Creative Proteomics’s Product Manager. “Creative Proteomics also uses flow cytometry (FACS analysis) and enzyme-linked immunosorbent assay (ELISA) to perform simultaneous quantitative ...
Kadimastem has raised more than 50 million NIS ($15.9 million) since the beginning of 2021, with the arrival of its current management team, led by biotechnology industry moguls Chairman of the Board Mr. ...
This development allows clinical laboratories to access leading innovations in liquid chromatography (LC) and mass spectrometry (MS) technology for the analysis of a variety of compounds that include diagnostic indicators in laboratory-developed tests. ...
(NYSE: A) today introduced an enhanced version of its Dissolution Workstation Software, providing better data integration, method change control and instrument monitoring for controlling multiple dissolution systems. ...
Due to its exceptional expertise in the area of informatics, the processes, including sample collection, processing, testing, storage and data management, can be managed seamlessly. "Whether clients are building, expanding, or sustaining their own in-house biorepositories or needing to outsource the storage of their samples, Thermo Fisher's ...
Waters Corporation (WAT:NYSE) and Ireland’s National Institute for Bioprocessing Research and Training (NIBRT) announced today a collaboration that will create the world’s first database for glycan analysis by UltraPerformance Liquid Chromatography (UPLC). Expected to be available in 2011, NIBRT will develop, maintain and license the database while Waters and NIBRT will co-market it ...
Waters new ACQUITY UPLC SEC solution makes it faster and easier for manufacturers to achieve high-confident data that meets FDA requirements for quantifying protein aggregates suspected of being capable of producing an immunogenic response in certain patients. ...